RF ablation effective for treating inoperable lung cancer
Mar 27, 2007 - 1:02:46 AM
, Reviewed by: Dr. Rashmi Yadav
|
|
|
"Our study has shown that this minimally invasive procedure can successfully treat patients with lung cancer who could not undergo surgery in one fairly simple treatment."
|
|
Key Points of this article
|
|
Radiofrequency (RF) ablation is effective for treating lung cancer in patients who are not candidates for surgery.
|
|
The procedure involves using a specialized needle inserted through the skin to transmit high-frequency electrical currents into a tumor.
|
|
The overall results of the study show RF ablation to be safe and linked it with promising long-term survival and local tumor progression outcomes when compared to the older treatment method of external beam radiation (EBT).
|
|
|
|
|
External Beam Radiation (EBT) Vs RF ablation
|
EBT, which has been used for decades, requires many treatments over a six-week period. This can often lead to a variety of side effects. RF ablation, however, is performed in a single day on an outpatient basis, is minimally invasive and has few side effects.
|
|
By Lifespan,
[RxPG] A minimally invasive procedure known as radiofrequency (RF) ablation is effective for treating lung cancer in patients who are not candidates for surgery, according to a Rhode Island Hospital study published in the April issue of the journal Radiology.
Damian Dupuy, MD, director of ablation at Rhode Island Hospital and professor of diagnostic imaging at The Warren Alpert Medical School of Brown University, conducted a study of 153 patients who were treated for early-stage, inoperable lung cancer with RF ablation. The procedure involves using a specialized needle inserted through the skin to transmit high-frequency electrical currents into a tumor. The overall results of the study show RF ablation to be safe and linked it with promising long-term survival and local tumor progression outcomes when compared to the older treatment method of external beam radiation (EBT).
EBT, which has been used for decades, requires many treatments over a six-week period. This can often lead to a variety of side effects. RF ablation, however, is performed in a single day on an outpatient basis, is minimally invasive and has few side effects.
Dupuy says, "Our study has shown that this minimally invasive procedure can successfully treat patients with lung cancer who could not undergo surgery in one fairly simple treatment. The study also shows that radiofrequency ablation is equal to or more effective in terms of both survival and tumor control." With RF ablation, the Rhode Island Hospital researchers noted a two-year survival rate at 57 percent compared to 51 percent using EBT.
"With lung cancer screening for at-risk individuals on the horizon, we will be able to detect lung cancers at earlier stages. In my lifetime, I foresee image-guided radiofrequency ablation replacing many surgical procedures for the treatment of cancer as we continue to improve these minimally invasive treatment methods."
Other survival rates for stage I, non-small cell cancer treated with RF ablation were 78 percent for one year, 57 percent for two years, 36 percent for three years and 27 percent for both four and five years.
Advertise in this space for $10 per month.
Contact us today.
|
 |
|
Subscribe to Radiology Newsletter
|
|
|
|
About Dr. Rashmi Yadav
|
This news story has been reviewed by Dr. Rashmi Yadav before its publication on RxPG News website. Dr. Rashmi Yadav, MBBS, is a senior editor for RxPG News. In her position she is responsible for managing special correspondents and the surgery section of the website. Her areas of special interest include cardiothoracic surgery and interventional radiology.
RxPG News is committed to promotion and implementation of Evidence Based Medical Journalism in all channels of mass media including internet.
|
|
Additional information about the news article
|
Founded in 1863, Rhode Island Hospital (www.rhodeislandhospital.org) is a private, not-for-profit hospital and is the largest teaching hospital of The Warren Alpert Medical School of Brown University. A major trauma center for southeastern New England, the hospital is dedicated to being on the cutting edge of medicine and research. Rhode Island Hospital ranks 15th among independent hospitals who receive funding from the National Institutes of Health, with research awards of nearly $27 million annually. Many of its physicians are recognized as leaders in their respective fields of cancer, cardiology, diabetes, orthopedics and minimally invasive surgery. The hospital's pediatrics division, Hasbro Children's Hospital, has pioneered numerous procedures and is at the forefront of fetal surgery, orthopedics and pediatric neurosurgery. Rhode Island Hospital is a founding member of the Lifespan health system.
|
|
Feedback
|
For any corrections of factual information, to contact the editors or to send
any medical news or health news press releases, use
feedback form
|
Top of Page
|
